Deferred Income Tax Assets, Net of Indivior Pharmaceuticals, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary: Indivior Pharmaceuticals, Inc. quarterly Deferred Income Tax Assets, Net in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
Indivior Pharmaceuticals, Inc. Deferred Income Tax Assets, Net for the quarter ending 31 Dec 2025 was $323,000,000, a 17% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Income Tax Assets, Net, Quarterly (USD)

Deferred Income Tax Assets, Net, YoY Quarterly Change (%)

Indivior Pharmaceuticals, Inc. Quarterly Deferred Income Tax Assets, Net (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$323,000,000	+$46,000,000	+17%	31 Dec 2025	10-K	26 Feb 2026	2025	FY
Q3 2025	$285,000,000			30 Sep 2025	10-Q	30 Oct 2025	2025	Q3
Q2 2025	$270,000,000			30 Jun 2025	10-Q	31 Jul 2025	2025	Q2
Q1 2025	$279,000,000			31 Mar 2025	10-Q	01 May 2025	2025	Q1
Q4 2024	$277,000,000	-$9,000,000	-3.1%	31 Dec 2024	10-K	26 Feb 2026	2025	FY
Q4 2023	$286,000,000			31 Dec 2023	10-K	26 Feb 2026	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.